Trastuzumab Deruxtecan for HER2-Positive Breast Cancer Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: a systematic review and meta-analysis
ESMO Open 2024 Feb 05;9(2)102233, I Michelon, M Vilbert, AD Marinho, CER Castro, MI Dacoregio, C Stecca, LR Soares, MV Batista, S Braga, A Saeed, L CavalcanteFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.